A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Public ClinicalTrials.gov record NCT05912517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Study identification
- NCT ID
- NCT05912517
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Nipocalimab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2023
- Primary completion
- Aug 4, 2027
- Completion
- Oct 7, 2029
- Last update posted
- May 7, 2026
2023 – 2029
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California at San Diego | La Jolla | California | 92037 | Recruiting |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | 90027 | Recruiting |
| UC Davis School of Medicine | Sacramento | California | 95817 | Recruiting |
| Childrens Hospital Colorado | Aurora | Colorado | 80045 | Recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| Advocate Children's Hospital | Park Ridge | Illinois | 60068 | Recruiting |
| Riley Children s Hospital | Indianapolis | Indiana | 46202 | Recruiting |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536 | Recruiting |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Recruiting |
| Midwest Fetal Care Center | Minneapolis | Minnesota | 55404 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| University of North Carolina (UNC) - School of Medicine | Chapel Hill | North Carolina | 27599-7516 | Recruiting |
| University of Cincinnati | Cincinnati | Ohio | 45267 | Recruiting |
| Oregon Health and Science University | Portland | Oregon | 97239 | Recruiting |
| Lehigh Valley Hospital | Allentown | Pennsylvania | 18103-6218 | Recruiting |
| University of Texas Dell Medical School Department of Women's Health | Austin | Texas | 78723 | Recruiting |
| University Of Texas Medical Branch At Galveston | Galveston | Texas | 77555 | Recruiting |
| Macon & Joan Brock Virginia Health Sciences at Old Dominion University | Norfolk | Virginia | 23507 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05912517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05912517 live on ClinicalTrials.gov.